Establishment of Madin-Darby canine kidney cell line with high P-glycoprotein expression

Chinese Pharmaceutical Journal

Volumn 44, Issue 21, 2009, Pages 1608-1613

  Liu, Yao ^a   Yu, Chun Na ^a   Zeng, Su ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Efflux; Madin Darby canine kidney cell; Multidrug resistance 1; P glycoprotein; Transport

Indexed keywords

CYCLOSPORIN; KETOCONAZOLE; LIPOFECTAMINE; QUININE; RHODAMINE 123; VERAPAMIL;

ANIMAL CELL; ARTICLE; CELL STRAIN; DRUG TRANSPORT; FLUORESCENCE; GENETIC TRANSFECTION; KIDNEY CELL; MOLECULAR CLONING; MULTIDRUG RESISTANCE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 71949096167     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. JULIANO R L, LING V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants[J]. Biochim Biophys Acta, 1976, 455(1):152-162.
2. WACHER V J, SALPHATI L, BENETL Z. Active secretion and enterocytic drug metabolism barriers to drug absorption[J]. Adv Drug Deliv Rev, 2001, 46(1-3):89-102. (Pubitemid 33653416)
3. LIN J H. Drug-drug interaction mediated by inhibition and induction of P-glycoprotein[J]. Adv Drug Deliv Rev, 2003, 55(1):53-81.
4. BRAUN A, HÄMMERLE S, SUDA K, et al. Cell cultures as tools in biopharmacy[J]. Eur J Pharm Sci, 2000, 11(Suppl 2): 51-60.
5. CHO M J, THOMPSON D P, CRAMER C T, et al. The madin darby canine kidney (MDCK) epithelial cell monolayer as a model cellular transport barrier[J]. Pharm Res, 1989, 6(1):71-77. (Pubitemid 19060827)
6. IRVINE J D, TAKAHSHI L, LOCKHART K, et al. MDCK (Madin-Darby canine kedney) cells: A tool for membrane permeability screening[J]. J Pharm Sci, 1999, 88(1):28-33.
7. SIMONS K, IKONEN E. Functional rafts in cell membranes[J]. Nature, 1997, 387(6633):569-572.
8. LUKER G D, PICA C M, KUMAR A S, et al. Effects of cholesterol and enantiomeric cholesterol on P-glycoprotein localization and function in low-density membrane domains[J]. Biochemistry, 2000, 39(26):7651-7661.
9. TANG F, HORIE K, BORCHARDT R T. Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa[J]. Pharm Res, 2002, 19(6):765-772. (Pubitemid 34686734)
10. GUMBLETON M, AUDUS K L. Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier[J]. J Pharm Sci, 2001, 90(11):1681-1698.
11. HÄMMERLE S P, ROTHEN-RUTISHAUSER B, KRÄMER S D, et al. P-Glycoprotein in cell cultures: a combined approach to study expression, localisation, and functionality in the confocal microscope[J]. Eur J Pharm Sci, 2000, 12 (1):69-77.
12. TANG F, OUYANG H, YANG J Z, et al. Bidirectional transport of rhodamine 123 and Hoechst 33342, fluorescence probes of the binding sites on P-glycoprotein, across MDCK-MDR1 cell monolayers[J]. J Pharm Sci, 2004, 93(5): 1185-1194.
13. MAHAR DOAN K M, HUMPHREYS J E, WEBSTER L O, et al. Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs[J]. J Pharmacol Exp Ther, 2002, 303(3):1029-1037.
14. ZHOU L, CHEN X, GU Y, et al. Transport characteristics of candesartan in human intestinal Caco-2 cell line[J]. Biopharm Drug Dispos, 2009, 30(5):259-264.
15. ANDERLE P, NIEDERER E, RUBAS W, et al. P-glycoprotein (P-gp) mediated efflux in Caco-2 monolayers: the influence of culturing conditions and drug exposure on P-gp expression levels[J]. J Pharm Sci, 1998, 87(6):757-762.
16. ZHOU L, CHEN X, GU Y, et al. Transport characteristics of candesartan in human intestinal Caco-2 cell line[J]. Biopharm Drug Dispos, 2009, 30(5):259-264.
17. ROTHEN-RUTISHAUSER B, BRAUN A, GÜNTHERT M, et al. Formation of multilayers in the Caco-2 cell culture model: a confocal laser scanning microscopy study[J]. Pharm Res, 2000, 17(4):460-465. (Pubitemid 30395302)
18. PRIME-CHAPMAN H M, FEARN R A, COOPER A E, et al. Differential multidrug resistance-associate protein 1 through 6 isoform expression and function in human intestinal epithelial Caco-2 cells[J]. J Pharmacol Exp Ther, 2004, 311(2):476-484.
19. RODRIGUES A C, CURI R, GENVIGIR F C, e al. The expression of efflux and uptake transporters are regulated by statins in Caco-2 and HepG2 cells[J]. Acta Pharmacol Sin, 2009, 30(7): 956-964.
20. WANG Y, CAO J, ZENG S. Establishment of a P-glycoprotein substrate screening model and its preliminary application [J]. World J Gastroenterol, 2004, 10(9):1365-1368. (Pubitemid 39162450)
21. WANG Y, CAO J, ZENG S. Involvement of P-glycoprotein in regulating cellular levels of Ginkgo flavonols: quercetin, kaempferol, and isorhamnetin[J]. J Pharm Pharmacol, 2005, 57(6):751-758.
22. WANG Y, CAO J, WENG J H, et al. Simultaneous determination of quercetin, kaempferol and isorhamnetin accumulated human beast cancer cells, by high-performance liquid chromatography[J]. J Pharm Biomed Anal, 2005, 39(1-2):328-333.
23. POLLI J W, WRING S A, HUMPHREYS J E, et al. Rational use of in vitro P-glycoprotein assays in drug discovery[J]. J Pharmacol Exp Ther, 2001, 299(2):620-628.
24. GOH L B, SPEARS K J, YAO D, et al. Endogenous drug transporters in in vitro and in vivo models for the prediction of drug disposition in man[J]. Biochem Pharmacol, 2002, 64(11):1569-1578. (Pubitemid 35333418)
25. LUO S, WANG Z, KANSARA V, et al. Activity of a sodium-dependent vitamin C transporter (SVCT) in MDCK-MDR1 cells and mechanism of ascorbate uptake[J]. Int J Pharm, 2008, 358(1-2):168-176.
26. BRAVDEN D J, GRIFFIN J. Avermectin transepithelial transport in MDR1- and MRP-transfected canine kidney monolayers.[J]. Vet Res Commun, 2008, 32(1):93-106.
27. ZHANG Y, BENET L Z. Characterization of P-glycoprotein mediated transport of K02, a novel vinylsulfone peptidomimetic cysteine protease inhibitor, across MDR1-MDCK and Caco-2 cell monolayers[J]. Pharm Res, 1998, 15(10):1520-1524.
28. WANG Q, RAGER J D, WEINSTEIN K, et al. Evaluation of the MDR-MDCK cell line as a permeability screen for the bloodrain barrier[J]. Int J Pharm, 2005, 288(2):349-359.
29. KARYEKAR C S, EDDINGTON N D, GARIMELLA T S, et al. Evaluation of P-glycoprotein-mediated renal drug interactions in an MDR1-MDCK model[J]. Pharmacotherapy, 2003, 23(4):436-442.